These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 33683765)

  • 21. TRPV4 inhibition prevents paclitaxel-induced neurotoxicity in preclinical models.
    Boehmerle W; Huehnchen P; Lee SLL; Harms C; Endres M
    Exp Neurol; 2018 Aug; 306():64-75. PubMed ID: 29715474
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Alphalipoic Acid Prevents Oxidative Stress and Peripheral Neuropathy in Nab-Paclitaxel-Treated Rats through the Nrf2 Signalling Pathway.
    Sun H; Guo X; Wang Z; Wang P; Zhang Z; Dong J; Zhuang R; Zhou Y; Ma G; Cai W
    Oxid Med Cell Longev; 2019; 2019():3142732. PubMed ID: 30881589
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Integrating Image-Based High-Content Screening with Mouse Models Identifies 5-Hydroxydecanoate as a Neuroprotective Drug for Paclitaxel-Induced Neuropathy.
    Chen LH; Sun YT; Chen YF; Lee MY; Chang LY; Chang JY; Shen MR
    Mol Cancer Ther; 2015 Oct; 14(10):2206-14. PubMed ID: 26294744
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Integrins protect sensory neurons in models of paclitaxel-induced peripheral sensory neuropathy.
    Shin GJ; Pero ME; Hammond LA; Burgos A; Kumar A; Galindo SE; Lucas T; Bartolini F; Grueber WB
    Proc Natl Acad Sci U S A; 2021 Apr; 118(15):. PubMed ID: 33876743
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Alpha-lipoic acid prevents mitochondrial damage and neurotoxicity in experimental chemotherapy neuropathy.
    Melli G; Taiana M; Camozzi F; Triolo D; Podini P; Quattrini A; Taroni F; Lauria G
    Exp Neurol; 2008 Dec; 214(2):276-84. PubMed ID: 18809400
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Chemotherapy-induced peripheral neuropathy in a dish: dorsal root ganglion cells treated in vitro with paclitaxel show biochemical and physiological responses parallel to that seen in vivo.
    Li Y; Marri T; North RY; Rhodes HR; Uhelski ML; Tatsui CE; Rhines LD; Rao G; Corrales G; Abercrombie TJ; Johansson CA; Dougherty PM
    Pain; 2021 Jan; 162(1):84-96. PubMed ID: 32694383
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Peptidergic intraepidermal nerve fibers in the skin contribute to the neuropathic pain in paclitaxel-induced peripheral neuropathy.
    Ko MH; Hu ME; Hsieh YL; Lan CT; Tseng TJ
    Neuropeptides; 2014 Jun; 48(3):109-17. PubMed ID: 24630273
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Comparison of neuropathy-inducing effects of eribulin mesylate, paclitaxel, and ixabepilone in mice.
    Wozniak KM; Nomoto K; Lapidus RG; Wu Y; Carozzi V; Cavaletti G; Hayakawa K; Hosokawa S; Towle MJ; Littlefield BA; Slusher BS
    Cancer Res; 2011 Jun; 71(11):3952-62. PubMed ID: 21498637
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Sensory neuron subpopulation-specific dysregulation of intracellular calcium in a rat model of chemotherapy-induced peripheral neuropathy.
    Yilmaz E; Gold MS
    Neuroscience; 2015 Aug; 300():210-8. PubMed ID: 25982563
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Role of satellite cell-derived L-serine in the dorsal root ganglion in paclitaxel-induced painful peripheral neuropathy.
    Kiya T; Kawamata T; Namiki A; Yamakage M
    Neuroscience; 2011 Feb; 174():190-9. PubMed ID: 21118710
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Discovery of Potential Neuroprotective Agents against Paclitaxel-Induced Peripheral Neuropathy.
    Chen YF; Wu CH; Chen LH; Lee HW; Lee JC; Yeh TK; Chang JY; Chou MC; Wu HL; Lai YP; Song JS; Yeh KC; Chen CT; Lee CJ; Shia KS; Shen MR
    J Med Chem; 2022 Mar; 65(6):4767-4782. PubMed ID: 35234475
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Role of Transient Receptor Potential Channels in Paclitaxel- and Oxaliplatin-induced Peripheral Neuropathy].
    Taguchi K
    Yakugaku Zasshi; 2016; 136(2):287-96. PubMed ID: 26831807
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Nab-paclitaxel is an active drug in preclinical model of pediatric solid tumors.
    Zhang L; Marrano P; Kumar S; Leadley M; Elias E; Thorner P; Baruchel S
    Clin Cancer Res; 2013 Nov; 19(21):5972-83. PubMed ID: 23989978
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Peripheral Neuropathy Induced by Microtubule-Targeted Chemotherapies: Insights into Acute Injury and Long-term Recovery.
    Wozniak KM; Vornov JJ; Wu Y; Liu Y; Carozzi VA; Rodriguez-Menendez V; Ballarini E; Alberti P; Pozzi E; Semperboni S; Cook BM; Littlefield BA; Nomoto K; Condon K; Eckley S; DesJardins C; Wilson L; Jordan MA; Feinstein SC; Cavaletti G; Polydefkis M; Slusher BS
    Cancer Res; 2018 Feb; 78(3):817-829. PubMed ID: 29191802
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A Pilot, Phase II, Randomized, Open-Label Clinical Trial Comparing the Neurotoxicity of Three Dose Regimens of Nab-Paclitaxel to That of Solvent-Based Paclitaxel as the First-Line Treatment for Patients with Human Epidermal Growth Factor Receptor Type 2-Negative Metastatic Breast Cancer.
    Ciruelos E; Apellániz-Ruiz M; Cantos B; Martinez-Jáñez N; Bueno-Muiño C; Echarri MJ; Enrech S; Guerra JA; Manso L; Pascual T; Dominguez C; Gonzalo JF; Sanz JL; Rodriguez-Antona C; Sepúlveda JM
    Oncologist; 2019 Nov; 24(11):e1024-e1033. PubMed ID: 31023863
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Sustained Accumulation of Microtubule-Binding Chemotherapy Drugs in the Peripheral Nervous System: Correlations with Time Course and Neurotoxic Severity.
    Wozniak KM; Vornov JJ; Wu Y; Nomoto K; Littlefield BA; DesJardins C; Yu Y; Lai G; Reyderman L; Wong N; Slusher BS
    Cancer Res; 2016 Jun; 76(11):3332-9. PubMed ID: 27197173
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Targeting Axon Integrity to Prevent Chemotherapy-Induced Peripheral Neuropathy.
    Chine VB; Au NPB; Kumar G; Ma CHE
    Mol Neurobiol; 2019 May; 56(5):3244-3259. PubMed ID: 30117103
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Comparison of the efficacy of cryotherapy and compression therapy for preventing nanoparticle albumin-bound paclitaxel-induced peripheral neuropathy: A prospective self-controlled trial.
    Kanbayashi Y; Sakaguchi K; Ishikawa T; Ouchi Y; Nakatsukasa K; Tabuchi Y; Kanehisa F; Hiramatsu M; Takagi R; Yokota I; Katoh N; Taguchi T
    Breast; 2020 Feb; 49():219-224. PubMed ID: 31901783
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Lithium attenuates peripheral neuropathy induced by paclitaxel in rats.
    Pourmohammadi N; Alimoradi H; Mehr SE; Hassanzadeh G; Hadian MR; Sharifzadeh M; Bakhtiarian A; Dehpour AR
    Basic Clin Pharmacol Toxicol; 2012 Mar; 110(3):231-7. PubMed ID: 21917116
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Neuroimmune Consequences of eIF4E Phosphorylation on Chemotherapy-Induced Peripheral Neuropathy.
    Agalave NM; Mody PH; Szabo-Pardi TA; Jeong HS; Burton MD
    Front Immunol; 2021; 12():642420. PubMed ID: 33912169
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.